ENXTPA:PLX
ENXTPA:PLXDiversified Financial

Assessing Pluxee (ENXTPA:PLX) Valuation After A Steep 1-Year Share Price Decline

Pluxee (ENXTPA:PLX) has been on investors’ radar after recent share performance, with the stock showing a 2% decline over the past month and a 16% decline over the past 3 months. See our latest analysis for Pluxee. Zooming out, the recent 1-day share price return of a 2% decline and 7-day share price return of a 4.62% decline sit within a tougher patch, with the 1-year total shareholder return of a 39.72% decline pointing to fading momentum despite a latest share price of €12.79. If Pluxee’s...
ENXTPA:SOP
ENXTPA:SOPIT

A Look At Sopra Steria Group (ENXTPA:SOP) Valuation After Recent Share Price Gains

Why Sopra Steria Group (ENXTPA:SOP) is on investors’ radar today Sopra Steria Group (ENXTPA:SOP) has attracted attention after recent share price moves, with the stock up around 10% over the past month and roughly 11% in the past 3 months. See our latest analysis for Sopra Steria Group. Despite a recent 10.1% 1 month share price return and an 11.5% 3 month share price return, Sopra Steria Group’s year to date share price return is broadly flat. The 1 year total shareholder return of a 5.8%...
ENXTPA:ABVX
ENXTPA:ABVXBiotechs

Is Abivax (ENXTPA:ABVX) Quietly Reframing Its Ulcerative Colitis Strategy Around Obefazimod’s Phase 3 Pathway?

Abivax has outlined its 2026 corporate outlook, emphasizing obefazimod’s potential in ulcerative colitis after the December 2025 ABTECT Phase 3 DSMB meeting reported no new safety signals and over 80% patient completion of the 44‑week maintenance trial. An interesting takeaway is the company’s plan to leverage these Phase 3 data to pursue a US regulatory filing for obefazimod later in 2026, underscoring its ambitions in the ulcerative colitis treatment market. Next, we’ll examine how the...
ENXTPA:SGO
ENXTPA:SGOBuilding

Does Saint-Gobain’s LSE Exit Reveal a Deeper Shift in Its Capital-Market Strategy (ENXTPA:SGO)?

Compagnie de Saint-Gobain has announced it will voluntarily delist its London Stock Exchange secondary listing, effective 10 February 2026, citing persistently low trading volumes, while maintaining its primary listing on Euronext Paris. This move consolidates liquidity and market focus in Paris, leaving UK holders of CREST Depository Interests to consider converting into directly tradable Euronext Paris shares. We’ll now assess how concentrating trading on Euronext Paris, and the...
ENXTPA:ALO
ENXTPA:ALOMachinery

Is It Too Late To Reassess Alstom (ENXTPA:ALO) After Its Recent Share Price Recovery?

If you are wondering whether Alstom at €26.19 is attractively priced or not, this article will walk you through what the current market price may be implying about its value. The stock has posted returns of 4.1% over the last 7 days, 11.5% over 30 days, 1.9% year to date, 29.3% over 1 year and 12.1% over 3 years, while the 5 year return stands at a 39.0% decline. Recent headlines around Alstom have focused on the share price recovery over the past year and how sentiment has shifted after a...
ENXTPA:ACA
ENXTPA:ACABanks

Is Crédit Agricole (ENXTPA:ACA) Still Reasonably Priced After Its 38.5% One Year Rally?

If you are wondering whether Crédit Agricole at €17.32 is still reasonably priced after a strong run, this article will help you put that question into context. The share price has seen a 38.5% return over the past year and a very large gain over five years, while the recent 1.3% decline over 7 days and 2.6% drop year to date suggest sentiment has been more mixed in the short term. Recent headlines around large European banks have focused on capital strength, regulatory developments and how...
ENXTPA:FGR
ENXTPA:FGRConstruction

European Dividend Stocks Eiffage And 2 More Top Picks

As the European market continues to thrive, with the STOXX Europe 600 Index hitting new highs and closing 2025 with its strongest annual performance since 2021, investors are increasingly looking towards dividend stocks for stable returns amidst an improving economic backdrop. In this environment, a good dividend stock is often characterized by a consistent payout history and solid fundamentals that can withstand varying market conditions.
ENXTPA:CAP
ENXTPA:CAPIT

Is Capgemini (ENXTPA:CAP) Offering Value After A 8.7% One Year Share Price Decline

Wondering whether Capgemini at €143.20 is offering you good value today, or whether the price already reflects most of the upside? The share price is at €143.20 after a 0.1% gain over the last week, a 0.9% decline over the last month, a 1.7% gain year to date, and an 8.7% decline over the past year, while the 5 year return sits at 25.8%. Recent coverage around Capgemini has focused on its role as a major European IT and consulting group and how that positioning fits into long term digital...
ENXTPA:NEX
ENXTPA:NEXElectrical

Is Nexans (ENXTPA:NEX) Pricing In Long Term Grid Investment At €126.80?

Wondering whether Nexans at €126.80 is offering fair value today, or if the price has already baked in most of the opportunity? This piece is designed to help you frame that question clearly. The share price has had a mixed recent run, with a 0.2% return over the last 7 days, a 2.2% decline over 30 days, and returns of 1.2% decline year to date, 25.7% over 1 year, 53.0% over 3 years and 110.8% over 5 years that may catch your eye if you track performance over different timeframes. Recent...
ENXTPA:ML
ENXTPA:MLAuto Components

European Dividend Stocks To Consider In January 2026

As the European markets continue to show strength, with the STOXX Europe 600 Index reaching new highs and closing out 2025 with a robust annual return, investors are increasingly turning their attention to dividend stocks as a means of capitalizing on this positive economic backdrop. In such an environment, selecting dividend stocks that not only offer attractive yields but also demonstrate stability and growth potential can be an effective strategy for income-focused investors looking to...